Endogenous opioid peptides: multiple agonists and receptors
The DOI matches its Crossref record; 26 of the 27 references it cites were found in a registry or an index.
Abstract
Opioid peptides were assayed by inhibition of 3H-naloxone and 3H-leu-enkephalin binding in brain homogenates and by depression of contractions of the guinea pig ileum and mouse vas deferens. We conclude that the opioid peptidergic system has agonists of different characteristics which interact with more than one type of receptor.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Higher order brain regions (PFC; rACC) project to the PAG, the rostral ventral medulla, and the dorsal horn of the spinal cord to reduce the elaboration of spinal and supraspinal nociceptive processing through the release of endogenous opioids9,77,78 that largely bind with mu, delta, and kappa receptors.54,69”
From The neural mechanisms of mindfulness-based pain relief: a functional magnetic resonance imaging-based review and primer (2019) · cites this paper as [69]
Citations
Cites
Identification of two related pentapeptides from the brain with potent opiate agonist activity
Hughes, J., Smith, T. W., Kosterlitz, H. W., Fothergill, L. A., Morgan, B. A., & Morris, H. R. (1975) · Nature · doi:10.1038/258577a0 · Cited by 3,806
Self-citationMartin, W. R., Eades, C. G., Thompson, J. A., Huppler, R. E., & Gilbert, P. E. (1976) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)30536-7 · Cited by 2,992
Opiate Receptor: Demonstration in Nervous Tissue
Pert, C. B., & Snyder, S. H. (1973) · Science · doi:10.1126/science.179.4077.1011 · Cited by 2,388
Opiates and endogenous opioid peptides
Kelly, J. S., & Dingledine, R. (1977) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(77)90262-6 · Cited by 1,282
Stereospecific Binding of the Potent Narcotic Analgesic [ 3 H]Etorphine to Rat-Brain Homogenate
Simon, E. J., Hiller, J. M., & Edelman, I. (1973) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.70.7.1947 · Cited by 1,067
Elde, R., Hökfelt, T., Johansson, O., & Terenius, L. (1976) · Neuroscience · doi:10.1016/0306-4522(76)90063-4 · Cited by 775
C fragment of lipotropin has a high affinity for brain opiate receptors
BRADBURY, A. F., SMYTH, D. G., SNELL, C. R., BIRDSALL, N. J. M., & HULME, E. C. (1976) · Nature · doi:10.1038/260793a0 · Cited by 489
Gilbert, P. E., & Martin, W. R. (1976) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)30572-0 · Cited by 487
Choline esters in tissue extracts
Chang, H. C., & Gaddum, J. H. (1933) · The Journal of Physiology · doi:10.1113/jphysiol.1933.sp003049 · Cited by 486
[D-Ala 2 ]-Met-Enkephalinamide: A Potent, Long-Lasting Synthetic Pentapeptide Analgesic
Pert, C. B., Pert, A., Chang, J.-K., & Fong, B. T. (1976) · Science · doi:10.1126/science.968485 · Cited by 469
Research works printed but not linked: 14
- Guillemin, R., Ling, N. & Burgus, R. C. r. hebd. Sèanc. Acad. Sci., Paris D274, 783–785 (1976).
- Waterfield, A. A., Smokcum, R. W. J., Hughes, J., Kosterlitz, H. W. & Henderson, G. Eur. J. Pharmac. (in the press).
- Martin, W. R., Pharmac Rev. 19, 463–521 (1967).
- Martin, W. R., Eades, C. G., Thompson, J. A., Huppler, R. E. & Gilbert P. E. J. Pharmac. exp. Ther. 197, 517–532 (1976).
- Gilbert, P. E. & Martin, W. R. J. Pharmac. exp. Ther. 198, 66–82 (1976).
- Kosterlitz, H. W. & Watt, A. J. Br. J. Pharmac. 33, 266–276 (1968).
- Martin, W. R., Bell, J. A., Gilbert, P. E., Sloan, J. W. & Thompson, J. A. in Narcotic Antagonists: Naltrexone. NIDA Research Monograph 9 (ed. Julius, D & Renault, P.) 27–30 (Department of Health, Education and Welfare, Washington, D.C., 1976).
- Feldberg, W. & Smyth, D. G. J. Physiol., Lond. 260, 30P–31P (1976); 265, 25P–27P (1977).
- Pert, A. in Opiates and Endogenous Opioid Peptides(ed. Kosterlitz, H. W.) 87–94 (North-Holland, Amsterdam, 1976).
- Arunlakshana, O. & Schild, H. O. Br. J. Pharmac. 14, 48–58 (1959).
- Creese, I. & Snyder, S. H. J. Pharmac. exp. Ther. 194, 205–219 (1975).
- Simantov, R. & Snyder, S. H. in Opiates and Endogenous Opioid Peptides (ed. Kosterlitz, H. W.) 41–48 (North-Holland, Amsterdam, 1976).
- Smith, T. W., Hughes, J., Kosterlitz, H. W. & Sosa, R. P. in Opiates and Endogenous Opioid Peptides (ed. Kosterlitz, H. W.) 57–62 (North-Holland, Amsterdam, 1976).
- Simantov, R., Kuhar, M. J. & Snyder, S. H. Proc. natn. Acad. Sci. U.S.A. (in the press).
Cited by
Items 301–400 of 1,002
Stefano, G. B., Kream, R. M., & Zukin, R. S. (1980) · Brain Research · doi:10.1016/0006-8993(80)90626-5 · Cited by 107
Rabiner, E. A., Beaver, J., Makwana, A., Searle, G., Long, C., Nathan, P. J., Newbould, R. D., Howard, J., Miller, S. R., Bush, M. A., et al. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.29 · Cited by 106
U-50,488, a selective kappa opioid agonist: Comparison to other reputed kappa agonists
Voigtlander, P. F. V., & Lewis, R. A. (1982) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(82)80130-9 · Cited by 106
“Keywords: opioids, kappa, agonists Introduction Studies of the endorphins (Lord et al, 1977) and benzomorphan analogs (Martin et al, 1976) have led to the hypothesis of separate subclasses of opioid receptors.”
BackgroundCardiovascular consequences of endogenous opiate antagonism
Holaday, J. W. (1983) · Biochemical Pharmacology · doi:10.1016/0006-2952(83)90479-3 · Cited by 106
A protein-lipid model of the opiate receptor
Lee, N. M., & Smith, A. P. (1980) · Life Sciences · doi:10.1016/0024-3205(80)90266-0 · Cited by 106
Stengaard‐Pedersen, K., & Larsson, L. (1981) · Peptides · doi:10.1016/0196-9781(81)90050-4 · Cited by 105
Quock, R. M., Burkey, T. H., Varga, E. V., Hosohata, Y., Hosohata, K., Cowell, S. M., Slate, C. A., Ehlert, F. J., Roeske, W. R., & Yamamura, H. I. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01416-9 · Cited by 192
Endogenous Opioid Peptides and Hypothalamo-Pituitary Function
Howlett, T. A., & Rees, L. H. (1986) · Annual Review of Physiology · doi:10.1146/annurev.ph.48.030186.002523 · Cited by 105
Single potassium channels opened by opioids in rat locus ceruleus neurons.
Miyake, M., Christie, M. J., & North, R. A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.9.3419 · Cited by 105
Hayes, A. G., Sheehan, M. J., & Tyers, M. B. (1987) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1987.tb11281.x · Cited by 104
Affinity Labels for Opioid Receptors
Takemori, A. E., & Portoghese, P. S. (1985) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.25.040185.001205 · Cited by 104
Decrease in δ-opioid receptor density in rat brain after chronic [d-Ala2,d-Leu5]enkephalin treatment
Tao, P., Chang, L.-R., Law, P., & Loh, H. H. (1988) · Brain Research · doi:10.1016/0006-8993(88)90559-8 · Cited by 104
Involvement of the opioid system in the anxiolytic effect of diazepam in mice
Tsuda, M., Suzuki, T., Misawa, M., & Nagase, H. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00219-1 · Cited by 103
Potent antinociceptive effects of TRK-820, a novel κ-opioid receptor agonist
Endoh, T., Matsuura, H., Tajima, A., Izumimoto, N., Tajima, C., Suzuki, T., Saitoh, A., Suzuki, T., Narita, M., Tseng, L. F., et al. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00417-8 · Cited by 102
Sim, L. J., & Childers, S. R. (1997) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19971006)386:4<562::aid-cne4>3.0.co;2-0 · Cited by 102
Opiate and peptide interaction: Effect of enkephalins on morphine analgesia
Lee, N. M., Leybin, L., Chang, J. K., & Loh, H. H. (1980) · European Journal of Pharmacology · doi:10.1016/0014-2999(80)90319-2 · Cited by 102
Species differences in the concentrations and distributions of opioid binding sites
Robson, L. E., Gillan, M. G. C., & Kosterlitz, H. W. (1985) · European Journal of Pharmacology · doi:10.1016/0014-2999(85)90239-0 · Cited by 101
Self-citationThe epileptogenic spectrum of opiate agonists
SNEADIII, O., & Bearden, L. J. (1982) · Neuropharmacology · doi:10.1016/0028-3908(82)90171-x · Cited by 101
Opiate receptor localization in rat cerebral cortex
Lewis, M. E., Pert, A., Pert, C. B., & Herkenham, M. (1983) · Journal of Comparative Neurology · doi:10.1002/cne.902160310 · Cited by 100
Heyman, J. S., Vaught, J. L., Mosberg, H. I., Haaseth, R. C., & Porreca, F. (1989) · European Journal of Pharmacology · doi:10.1016/0014-2999(89)90764-4 · Cited by 100
Fowler, C. J., & Fraser, G. L. (1994) · Neurochemistry International · doi:10.1016/0197-0186(94)90089-2 · Cited by 113
Wüster, M., Schulz, R., & Herz, A. (1980) · Life Sciences · doi:10.1016/0024-3205(80)90459-2 · Cited by 100
Wang, J. B., Johnson, P. S., Wu, J. M., Wang, W. F., & Uhl, G. R. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47144-x · Cited by 99
Differential messenger RNA expression of prodynorphin and proenkephalin in the human brain
Hurd, Y. L. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00002-4 · Cited by 107
Naloxone enhancement of memory processes: Effects of other opiate antagonists
Gallagher, M. (1982) · Behavioral and Neural Biology · doi:10.1016/s0163-1047(82)91020-2 · Cited by 99
Kayser, V., Fournié‐Zaluski, M., Guilbaud, G., & Roques, B. P. (1989) · Brain Research · doi:10.1016/0006-8993(89)90974-8 · Cited by 99
The case for multiple opiate receptors
Zukin, R. S., & Zukin, S. R. (1984) · Trends in Neurosciences · doi:10.1016/s0166-2236(84)80128-9 · Cited by 98
OPIATE MEDIATION OF AMENORRHOEA IN HYPERPROLACTINAEMIA AND IN WEIGHT‐LOSS RELATED AMENORRHOEA
GROSSMAN, A., MOULT, P. J. A., McINTYRE, H., EVANS, J., SILVERSTONE, T., REES, L. H., & BESSER, G. M. (1982) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1982.tb01603.x · Cited by 99
Morphine inhibits substance P release from peripheral sensory nerve endings
Brodin, E., Gazelius, B., Panopoulos, P., & Olgart, L. M. (1983) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1983.tb07228.x · Cited by 98
Opiate antagonist receptor binding in vivo: evidence for a new receptor binding model
Perry, D. C., Mullis, K. B., Øie, S., & Sadée, W. (1980) · Brain Research · doi:10.1016/0006-8993(80)90229-2 · Cited by 97
Cyclic enkephalin analogs containing a cystine bridge
Schiller, P. W., Eggimann, B., DiMaio, J., Lemieux, C., & Nguyen, T. M. ‐. (1981) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(81)91265-1 · Cited by 97
Both ν and δ Opiate Receptors Exist on the Same Neuron
Egan, T. M., & North, R. A. (1981) · Science · doi:10.1126/science.6272393 · Cited by 97
Targeting opioid dysregulation in depression for the development of novel therapeutics
Browne, C. A., & Lucki, I. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.04.009 · Cited by 95
Sánchez‐Blázquez, P., García‐España, A., & Garzón, J. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36506-1 · Cited by 97
Mosberg, H. I., Hurst, R., Hruby, V. J., Galligan, J. J., Burks, T. F., Gee, K. W., & Yamamura, H. I. (1983) · Life Sciences · doi:10.1016/0024-3205(83)90239-4 · Cited by 96
Opiate receptor subclasses differ in their conformational requirements
Schiller, P. W., & DiMaio, J. (1982) · Nature · doi:10.1038/297074a0 · Cited by 95
Opiate (Enkephalin) Receptors of Neuroblastoma Cells: Occurrence in Clusters on the Cell Surface
Hazum, E., Chang, K., & Cuatrecasas, P. (1979) · Science · doi:10.1126/science.227058 · Cited by 95
Mihara, S., & North, R. A. (1986) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1986.tb10207.x · Cited by 95
Evidence for a δ-class opioid receptor on cells of the immune system
Carr, D. J. J., Kim, C.-H., DeCosta, B. R., Jacobson, A. E., Rice, K. C., & Blalock, J. E. (1988) · Cellular Immunology · doi:10.1016/0008-8749(88)90208-0 · Cited by 95
Chaillet, P., Coulaud, A., Zajac, J., Fournié‐Zaluski, M., Costentin, J., & Roques, B. P. (1984) · European Journal of Pharmacology · doi:10.1016/0014-2999(84)90033-5 · Cited by 95
Dynorphin–Still an Extraordinarily Potent Opioid Peptide
Chavkin, C. (2012) · Molecular Pharmacology · doi:10.1124/mol.112.083337 · Cited by 110
“the in vitro smooth muscle contraction bioassays (Lord et al., 1977).”
BackgroundCadet, P., Mantione, K. J., & Stefano, G. B. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.10.5118 · Cited by 94
“T he first demonstration by Kosterlitz and coworkers (1) that exogenous morphine can bind to receptors in mammalian brain indicated that morphine binds to the same sites as those used by the endogenous opioid peptides (e.”
BackgroundBeta-casomorphin (BCM) and human colonic lamina propria lymphocyte proliferation
Elitsur, Y., & Luk, G. D. (1991) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1991.tb05755.x · Cited by 94
Schneider, T., Ziółkowska, B., Gieryk, A., Tyminska, A., & Przewłocki, R. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0795-y · Cited by 101
“…et al. 2004; Ragnauth et al. 2001; Konig et al. 1996) and in rodents treated with antagonists of the δ-opioid receptor (Saitoh et al. 2005; Nieto et al. 2005), for which receptor the enkephalins are generally considered the preferred endogenous ligands (Lord et al. 1977; Akil et al. 1998).”
BackgroundConformation-activity relationships of opioid peptides with selective activities at opioid receptors
Hruby, V. J., & Agnes, R. S. (1999) · Biopolymers · doi:10.1002/(sici)1097-0282(1999)51:6<440::aid-bip6>3.0.co;2-t · Cited by 93
Cloning, Characterization, and Distribution of a μ‐Opioid Receptor in Rat Brain
Zastawny, R. L., George, S. R., Nguyen, T., Cheng, R., Tsatsos, J., Briones‐Urbina, R., & O'Dowd, B. F. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62062099.x · Cited by 93
The Molecular Basis of Opioid Receptor Function
Simonds, W. F. (1988) · Endocrine Reviews · doi:10.1210/edrv-9-2-200 · Cited by 94
The contribution of intrinsic activity to the action of opioids in vitro
Miller, L., Shaw, J. S., & Whiting, E. (1986) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1986.tb10202.x · Cited by 94
The effect of ethanol on the biosynthesis and regulation of opioid peptides
Gianoulakis, C. (1989) · Cellular and Molecular Life Sciences · doi:10.1007/bf01952024 · Cited by 95
Pittman, Q. J., Hatton, J. D., & Bloom, F. E. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.9.5527 · Cited by 94
Seybold, V., & Elde, R. (1984) · Journal of Neuroscience · doi:10.1523/jneurosci.04-10-02533.1984 · Cited by 94
“However, given the density of enkephalin- (Holets and Elde, 1982) and dynorphin-immunoreactive terminals in the IML (V. S. Seybold, unpublished observations), it is more likely that opiate effects in this region may be mediated by d or K receptors ( Lord et al., 1977; Chavkin et al., 1982).”
BackgroundMethodInfluentialSleep disturbances and pain among individuals with prescription opioid dependence
Hartwell, E. E., Pfeifer, J. G., McCauley, J. L., Maria, M. M. M., & Back, S. E. (2014) · Addictive Behaviors · doi:10.1016/j.addbeh.2014.05.025 · Cited by 97
“Conversely, neurobiological research indicates that use of exogenous opioids that block endogenous opioid peptide receptors are also active in the regulation of sleep, thereby impacting sleep architecture and contributing to increased latency of sleep onset, decreased REM sleep, increased waking bouts, and greater sle…”
BackgroundPan, Y., Xu, J., Bolan, E. A., Moskowitz, H. S., Xu, M., & Pasternak, G. W. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.011858 · Cited by 93
“After the classification of the -, -, and -opioid receptors (Martin et al., 1976; Lord et al., 1977; Kosterlitz and Leslie, 1978), drugs were classified by their selectivity profiles in receptor-binding assays.”
BackgroundProlactin and Growth Hormone Release by Morphine in the Rat: Different Receptor Mechanisms
Spiegel, K., KOURIDES, I. A., & Pasternak, G. W. (1982) · Science · doi:10.1126/science.6285470 · Cited by 93
Multiple opiate receptors: [3H]ethylketocyclazocine receptor binding and ketocyclazocine analgesia.
Pasternak, G. W. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.6.3691 · Cited by 93
Goodman, R. R., & Pasternak, G. W. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.19.6667 · Cited by 93
Endogenous opioid systems alterations in pain and opioid use disorder
Higginbotham, J. A., Markovic, T., Massaly, N., & Morón, J. A. (2022) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2022.1014768 · Cited by 111
“Pharmacological analysis revealed a third opioid receptor type in the mouse vas deferens that exhibited a pharmacological profile markedly different from those previously identified (μ and κ) and was accordingly, named delta (δ) to signify this difference (Lord et al., 1977).”
BackgroundNieto, M. M., Guen, S. L., Kieffer, B. L., Roques, B. P., & Noble, F. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.06.025 · Cited by 93
Morphine-induced place preference in the CXBK mouse: characteristics of μ opioid receptor subtypes
Suzuki, T., Funada, M., Narita, M., Misawa, M., & Nagase, H. (1993) · Brain Research · doi:10.1016/0006-8993(93)90239-j · Cited by 96
Circulating opioids: Possible physiological roles in central nervous function
Henry, J. L. (1982) · Neuroscience & Biobehavioral Reviews · doi:10.1016/0149-7634(82)90040-9 · Cited by 96
Chang, K., Cuatrecasas, P., Wei, E. T., & Chang, J. K. (1982) · Life Sciences · doi:10.1016/0024-3205(82)90242-9 · Cited by 93
Striatal met-enkephalin concentration increases following nigrostriatal denervation
Thal, L. J., Sharpless, N. S., Hirschhorn, I. D., Horowitz, S. G., & Makman, M. H. (1983) · Biochemical Pharmacology · doi:10.1016/0006-2952(83)90353-2 · Cited by 92
Danzebrink, R. M., Green, S. A., & Gebhart, G. F. (1995) · Pain · doi:10.1016/0304-3959(94)00275-j · Cited by 91
Saiani, L., & Guidotti, A. (1982) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1982.tb08001.x · Cited by 91
The human interferon ? species and receptors
Pestka, S. (2000) · Biopolymers · doi:10.1002/1097-0282(2000)55:4<254::aid-bip1001>3.0.co;2-1 · Cited by 157
β-Endorphin is Present in the Male Reproductive Tract of Five Species1
TSONG, S. D., Phillips, D. M., Halmi, N. S., Krieger, D. T., & Bardin, C. W. (1982) · Biology of Reproduction · doi:10.1095/biolreprod27.3.755 · Cited by 90
Cain, D. P., & Corcoran, M. E. (1985) · Brain Research · doi:10.1016/0006-8993(85)90163-5 · Cited by 90
Brantl, V., Pfeiffer, A. F. H., Herz, A., Henschen, A., & Lottspeich, F. (1982) · Peptides · doi:10.1016/0196-9781(82)90017-1 · Cited by 89
Bianchi, G., Fiocchi, R., Tavani, A., & Manara, L. (1982) · Life Sciences · doi:10.1016/0024-3205(82)90467-2 · Cited by 90
3H-dihydromorphine binding in brain regions of young and aged rats
Messing, R. B., Vásquez, B. J., Spiehler, V. R., Martinez, J. L., Jensen, R. A., Rigter, H., & McGaugh, J. L. (1980) · Life Sciences · doi:10.1016/0024-3205(80)90112-5 · Cited by 89
The evolution of vertebrate opioid receptors
Craig, W. S. (2009) · Frontiers in bioscience · doi:10.2741/3306 · Cited by 100
“Later, Hans Kosterlitz and colleagues, working with the newly discovered enkephalin peptides in the mouse vas deferens preparation, proposed a delta (for deferens; DOR) opioid receptor type (9).”
BackgroundDuwiejua, M., Woode, E., & Obiri, D. D. (2002) · Journal of Ethnopharmacology · doi:10.1016/s0378-8741(02)00058-2 · Cited by 88
Beczkowska, I. W., Bowen, W. D., & Bodnar, R. J. (1992) · Brain Research · doi:10.1016/0006-8993(92)91289-q · Cited by 88
Modulation of μ-mediated antinociception by δ agonists: characterization with antagonists
Heyman, J. S., Jiang, Q., Rothman, R. B., Mosberg, H. I., & Porreca, F. (1989) · European Journal of Pharmacology · doi:10.1016/0014-2999(89)90815-7 · Cited by 88
Daugé, V., Rossignol, P., & Roques, B. (1988) · Psychopharmacology · doi:10.1007/bf00216060 · Cited by 88
Opiate modulating properties of nociceptin/orphanin FQ☆
Harrison, L. M., & Grandy, D. K. (2000) · Peptides · doi:10.1016/s0196-9781(99)00185-0 · Cited by 93
Modulation of transmitter and hormone release by multiple neuronal opioid receptors
Illés, P. (2005) · Springer eBooks · doi:10.1007/bfb0027497 · Cited by 88
Tepperman, F. S., & Hirst, M. (1983) · European Journal of Pharmacology · doi:10.1016/0014-2999(83)90313-8 · Cited by 88
Strain differences in opiate receptors in mouse brain
Reith, M. E. A., Sershen, H. W., Vadász, C., & Lajtha, Á. (1981) · European Journal of Pharmacology · doi:10.1016/0014-2999(81)90059-5 · Cited by 88
Specific opiate receptors on isolated mammalian gastric smooth muscle cells
Bitar, K. N., & Makhlouf, G. M. (1982) · Nature · doi:10.1038/297072a0 · Cited by 88
Inhibition of vasopressin release in man by an opiate peptide
GROSSMAN, A. (1980) · The Lancet · doi:10.1016/s0140-6736(80)92542-8 · Cited by 88
INHIBITORY ACTIONS OF METHIONINE‐ENKEPHALIN AND MORPHINE ON THE CAT CAROTID CHEMORECEPTORS
McQueen, D. S., & Ribeiro, J. A. (1980) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1980.tb10939.x · Cited by 87
Kelly, D. D. (1982) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1982.tb39499.x · Cited by 86
Studies of the Mechanism of the Antidiarrheal Effect of Codeine
Schiller, L. R., Davis, G. R., Ana, C. A. S., Morawski, S. G., & Fordtran, J. S. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110711 · Cited by 86
OPIATE MODULATION OF THE PITUITARY‐ADRENAL AXIS: EFFECTS OF STRESS AND CIRCADIAN RHYTHM
GROSSMAN, A., GAILLARD, R. C., McCARTNEY, P., REES, L. H., & BESSER, G. M. (1982) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1982.tb01590.x · Cited by 86
Adler, M. W. (1980) · Life Sciences · doi:10.1016/0024-3205(80)90312-4 · Cited by 98
Duka, T., Schubert, P., Wüster, M., Stoiber, R., & Herz, A. (1981) · Neuroscience Letters · doi:10.1016/0304-3940(81)90368-2 · Cited by 86
The role of the opioid system in alcohol dependence
Nutt, D. J. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881113504017 · Cited by 85
“Cleavage of proenkephalin yields the production of met- and leu-enkephalin, both of which exhibit a high affinity for the DOP, and an approximately 10-fold lower affinity for the MOP, with negligible affinity for the KOP (Lord et al., 1977).”
BackgroundFrost, J. J., Mayberg, H. S., Sadzot, B., Dannals, R. F., Lever, J. R., Ravert, H. T., Wilson, A. A., Wagner, H. N., & Links, J. M. (1990) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1990.90 · Cited by 85
McNally, G. P. (1999) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(99)00040-8 · Cited by 95
“[135] Lord JA, Waterfield AA, Hughes J, Kosterlitz HW.”
BackgroundCalderon, S. N., Rice, K. C., Rothman, R. B., Porreca, F., Flippen-Anderson, J. L., Kayakiri, H., Xu, H., Becketts, K. M., Smith, L. E., Bilsky, E. J., et al. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm960319n · Cited by 85
Hazum, E., Sabatka, J. J., Chang, K.-J., Brent, D. A., Findlay, J. W. A., & Cuatrecasas, P. (1981) · Science · doi:10.1126/science.6267691 · Cited by 85
Naloxone alters alcohol drinking induced in the rat by tetrahydropapaveroline (THP) infused ICV
Myers, R. D., & Critcher, E. C. (1982) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(82)90243-x · Cited by 88
Studies on rat intestinal epithelial cell receptors for serotonin and opiates.
Gaginella, T. S., Rimele, T. J., & Wietecha, M. (1983) · The Journal of Physiology · doi:10.1113/jphysiol.1983.sp014522 · Cited by 83
Chang, K. J., Su, Y. F., Brent, D. A., & Chang, J. K. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)39296-7 · Cited by 84
Pharmacokinetic aspects of spinal morphine analgesia
Nordberg, G. F. (1984) · Acta Anaesthesiologica Scandinavica · doi:10.1111/j.1399-6576.1984.tb02148.x · Cited by 84
Analgesic, locomotor and lethal effects of morphine in the mouse: Strain comparisons
Moskowitz, A. S., Terman, G. W., Carter, K. R., Morgan, M. J., & Liebeskind, J. C. (1985) · Brain Research · doi:10.1016/0006-8993(85)91273-9 · Cited by 86
Shimohigashi, Y., English, M. L., Stammer, C. H., & Costa, T. (1982) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(82)90677-5 · Cited by 84
Matsuzawa, S., Suzuki, T., Misawa, M., & Nagase, H. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00008-4 · Cited by 88
INTRATHECAL DELTA-RECEPTOR LIGAND PRODUCES ANALGESIA IN MAN
Onofrio, B. M., & Yaksh, T. L. (1983) · The Lancet · doi:10.1016/s0140-6736(83)92170-0 · Cited by 83
Metadata
- Authors
- Lord, J. A. H., Waterfield, A. A., Hughes, J., & Kosterlitz, H. W.
- Affiliations
- University of Aberdeen (GB)
- ORCID
- Lord, John A. H.
- Venue
- Nature
- Published
- 1977-06
- Volume
- 267
- Issue
- 5611
- Pages
- 495-499
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2075811628
- Cited by
- 2,485
- References
- 27
- Citations by year
- 2026: 6 · 2025: 4 · 2024: 7 · 2023: 12 · 2022: 7 · 2021: 11 · 2020: 42 · 2019: 18 · 2018: 13 · 2017: 13 · 2016: 7 · 2015: 22 · 2014: 21 · 2013: 29 · 2012: 34
- FWCI
- 35.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Keywords
- endogenous opioids, opioid receptors, receptor agonists, naloxone binding, ileal smooth muscle contraction, vas deferens contraction, peptidergic systems
- MeSH terms
- Animals, Benzomorphans, Brain, Endorphins, Enkephalins, Guinea Pigs, Ileum, Male, Naloxone, Narcotic Antagonists, Narcotics, Oligopeptides, Peptides, Receptors, Opioid, Structure-Activity Relationship, Vas Deferens, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.